THERAPEUTIC USE OF PHAGE EXPRESSING TOXIN-BINDING AND/OR CYTOKINE- BINDING PROTEINS AND ELIMINATION OF GENES ASSOCIATED WITH LYSOGENY
US Application 60/025,167
Filed on 1996-08-29
Filed on 1996-08-29
DELETION OF LYSOGENY GENES AND TOXIN GENES FROM BACTERIOPHAGE USED IN THE EPIDEMIOLOGIC CONTROL OF BACTERIAL ILLNESS
US Application 60/019,392
Filed on 1996-08-29
Filed on 1996-08-29
SUCEPTIBILITY AND RESISTANCE GENES FOR BIPOLAR AFFECTIVE DISORDER
US Application 60/062,924
Filed on 1997-10-20
Filed on 1997-10-20
METHODS OF INDUCING IMMUNE TOLERANCE USING IMMUNOTOXINS
US Application 60/015,459
Filed on 1996-04-15
Filed on 1996-04-15
AN IMMUNOTOXIN WITH IV VIVO T CELL SUPPRESSANT ACTIVITY AND METHODS OF USE
US Application 60/008,104
Filed on 1995-10-30
Filed on 1995-10-30
SUSCEPTIBILITY GENES FOR BIPOLAR AFFECTIVE DISORDER
US Application 60/014,334
Filed on 1996-03-29
Filed on 1996-03-29
SYSTEMS AND METHODS FOR MULTICHANNEL INDIVIDUALIZED STIMULATION THERAPY
Patent Cooperation Treaty
PCT/US2024/023876
Filed on 2024-04-10
PCT/US2024/023876
Filed on 2024-04-10
Intranasal Administration Of Ketamine To Treat Depression
US Application 15/930,140
Filed on 2020-05-12
Filed on 2020-05-12
Intranasal Administration Of Ketamine To Treat Depression
US Application 16/844,090
Filed on 2020-04-09
Filed on 2020-04-09
RADIOLABELING AGENTS, METHODS OF MAKING, AND METHODS OF USE THEREOF
US Application 17/074,832
Filed on 2020-10-20
Filed on 2020-10-20